Skip to content

Comparison of the Effectiveness of Neurofeedback and Yoga on Enhancing Concentration, Attention, and Reducing Anxiety in Children Aged 6 to 11 with Attention-Deficit/Hyperactivity Disorder (ADHD)

Comparison of the Effectiveness of Neurofeedback and Yoga on Enhancing Concentration, Attention, and Reducing Anxiety in Children Aged 6 to 11 with Attention-Deficit/Hyperactivity Disorder (ADHD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250906067136N1
Enrollment
50
Registered
2025-09-09
Start date
2025-09-23
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit/Hyperactivity Disorder. Attention-deficit hyperactivity disorder, predominantly inattentive type

Interventions

Intervention 1: Intervention group: The intervention group will participate in a 24-session training program, each session lasting 60 minutes (30 minutes of neurofeedback + 30 minutes of yoga), conduc

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 11 Years

Inclusion criteria

Inclusion criteria: Having a confirmed diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) by the school counselor as well as through ADHD questionnaires. The child’s age should be between 6 and 11 years (completed). Having an Intelligence Quotient (IQ) within the normal range (typically 90–110 or higher), as measured by the Wechsler Intelligence Scale for Children (WISC-IV). No use of psychiatric medications during the past three months. Obtaining written informed consent from the child’s parents for participation in the study.

Exclusion criteria

Exclusion criteria: Presence of severe comorbid psychiatric disorders or serious comorbid conditions such as psychotic disorders, severe major depressive disorder, bipolar disorder, or autism spectrum disorders. Presence of neurophysiological disorders such as a history of epilepsy, seizures, severe head trauma, or any known neurological condition that may affect brain function and EEG. Regular participation of the child in other psychotherapy sessions (such as play therapy, art therapy) or any other interventions that directly affect attention and anxiety during the study period. Presence of severe sensory (blindness, deafness) or motor impairments that make participation in yoga sessions or sitting still during neurofeedback sessions impossible. Lack of willingness of the child or family to consistently comply with the research protocol (regular attendance at sessions, completing questionnaires) or their request to withdraw from the study at any stage.

Design outcomes

Primary

MeasureTime frame
Attention-Deficit/Hyperactivity. Timepoint: Measurements will be conducted at pre-test, post-test, and three-month follow-up after the post-test. Method of measurement: Integrated Visual and Auditory Continuous Performance Test.;Children's Anxiety. Timepoint: Measurements will be conducted at pre-test, post-test, and three-month follow-up after the post-test. Method of measurement: Spence Children's Anxiety Scale - SCAS.;Attention-Deficit/Hyperactivity. Timepoint: Measurements will be conducted at pre-test, post-test, and three-month follow-up after the post-test. Method of measurement: Swanson, Nolan, and Pelham Rating Scale – Fourth Edition (SNAP-IV).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSogand Shahwar

Islamic Azad University

sogand.shahwar@aui.ir+98 61 3227 1486

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026